25 related articles for article (PubMed ID: 15940021)
1. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia.
Yamamoto T; Yuki S; Watanabe T; Mitsuka M; Saito KI; Kogure K
Brain Res; 1997 Jul; 762(1-2):240-2. PubMed ID: 9262182
[TBL] [Abstract][Full Text] [Related]
2. Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats.
Ikeda T; Xia YX; Kaneko M; Sameshima H; Ikenoue T
Neurosci Lett; 2002 Aug; 329(1):33-6. PubMed ID: 12161256
[TBL] [Abstract][Full Text] [Related]
3. Role of mitochondrial permeability transition in fetal brain damage in rats.
Nakai A; Shibazaki Y; Taniuchi Y; Miyake H; Oya A; Takeshita T
Pediatr Neurol; 2004 Apr; 30(4):247-53. PubMed ID: 15087102
[TBL] [Abstract][Full Text] [Related]
4. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats.
Shibazaki Y; Nakai A; Koshino T; Yokoyama K
Brain Res; 2001 Feb; 892(2):351-8. PubMed ID: 11172783
[TBL] [Abstract][Full Text] [Related]
5. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver.
Okatani Y; Wakatsuki A; Enzan H; Miyahara Y
Eur J Pharmacol; 2003 Mar; 465(1-2):163-70. PubMed ID: 12650846
[TBL] [Abstract][Full Text] [Related]
6. Maternal treatment with MCI-186 does not improve delayed deterioration of cellular bioenergetic state and mitochondrial activity following transient intrauterine ischemia in the fetal rat brain.
Yokota A; Nakai A; Taniuchi Y; Okuda N; Nakai M; Takeshita T
J Nippon Med Sch; 2005 Apr; 72(2):127-30. PubMed ID: 15940021
[TBL] [Abstract][Full Text] [Related]
7. Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia.
Nakai A
J Nippon Med Sch; 2007 Jun; 74(3):190-201. PubMed ID: 17625367
[TBL] [Abstract][Full Text] [Related]
8. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
11. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.
Higashi Y
Expert Opin Pharmacother; 2009 Feb; 10(2):323-31. PubMed ID: 19236202
[TBL] [Abstract][Full Text] [Related]
12. Energy utilization in the ischemic/reperfused brain.
Phillis JW; O'Regan MH
Int Rev Neurobiol; 2002; 51():377-414. PubMed ID: 12420365
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
